PF-Atlas › Clinical Trials › NCT04038710
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
Triple combination therapy · Not specified
Registry ID
NCT04038710
Phase
Not specified
Status
Completed
Drug / intervention
Triple combination therapy
Sponsor
National Jewish Health
Start
2019-09-05
About this trial
Triple combination therapy is evaluated in NCT04038710, a idiopathic pulmonary fibrosis study sponsored by National Jewish Health. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04038710 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.